FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RXQ Compounding Pyridoxine Recall

PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit…

RXQ Compounding LLC · Athens, OH

Risk level
Class II
Reported by FDA
Aug 14, 2019
Recall ID
D-1699-2019
Check your lot numberHow we source this data

Summary

RXQ Compounding recalled Pyridoxine starting Jun 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1699-2019 on Aug 14, 2019. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30

Lot numbers, UPCs & expiration codes

All lots within expiry

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1699-2019
Classification
Class II
Status
Terminated
Recall initiated
Jun 19, 2019
FDA report date
Aug 14, 2019
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
RXQ Compounding LLC

Original FDA data

Every field from FDA enforcement report D-1699-2019, exactly as published.

Show all FDA fields
City
Athens
State
OH
Status
Terminated
Country
United States
Event ID
83074
Address
340 W State St Unit 9
Code information
All lots within expiry
Postal code
45701-1564
Report date
Aug 14, 2019
Product type
Drugs
Recall number
D-1699-2019
Classification
Class II
Recalling firm
RXQ Compounding LLC
Termination date
Sep 16, 2022
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30
Distribution pattern
Nationwide USA
Recall initiation date
Jun 19, 2019
Initial firm notification
Press Release
Center classification date
Aug 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1699-2019, published Aug 14, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls